“…It has also been found that the medical and psychiatric comorbidities are greater in patients with ARFID than their AN counterparts (Becker et al., 2019; Bryson et al., 2018; Fisher et al., 2014; Lieberman et al., 2019; Norris et al., 2014). In psychiatric terms, higher rates of comorbidity in ARFID have been found with anxiety disorders, while in the case of AN, the higher rates are with mood disorders (Bryson et al., 2018; Cooney et al., 2018; Fisher et al., 2014; Katzman et al., 2019; Mammel & Ornstein, 2017; Menzel, Reilly, Luo, & Kaye, 2019; Nicely et al., 2014; Norris et al., 2014). Autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), obsessive‐compulsive disorder (OCD), and learning disorders are more prevalent in ARFID than in AN (Beighley et al., 2013; Bryson et al., 2018; Coglan & Otasowie, 2019; Cooney et al., 2018; Eddy et al., 2015; Fisher et al., 2014; Katzman et al., 2019; J. Lucarelli et al., 2017; Nicely et al., 2014; Norris et al., 2014; Ornstein et al., 2017; Pennell et al., 2016; Thomas et al., 2017; Zimmerman & Fisher, 2017).…”